Clinical trial
A Randomized, Placebo-controlled, Evaluator-blinded, Study to Assess the Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Patients With Inflammatory Facial Acne
NCT03883269 is registered in ClinicalTrials.gov with Centre for Human Drug Research, Netherlands as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo-controlled, Evaluator-blinded, Study to Assess the Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Patients With Inflammatory Facial Acne
- Lead sponsor
- Centre for Human Drug Research, Netherlands
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- March 20, 2018
- Completion date
- December 31, 2019
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.